Jessica H Hayward1, Kimberly M Ray2, Dorota J Wisner3, Bonnie N Joe4. 1. Department of Radiology and Biomedical Imaging, University of California, San Francisco, 1600 Divisadero St., Room C250, San Francisco, CA 94115, USA. Electronic address: jessica.hayward@ucsf.edu. 2. Department of Radiology and Biomedical Imaging, University of California, San Francisco, 1600 Divisadero St., Room C250, San Francisco, CA 94115, USA. Electronic address: kimberly.ray@ucsf.edu. 3. Department of Radiology and Biomedical Imaging, University of California, San Francisco, 1600 Divisadero St., Room C250, San Francisco, CA 94115, USA. 4. Department of Radiology and Biomedical Imaging, University of California, San Francisco, 1600 Divisadero St., Room C250, San Francisco, CA 94115, USA. Electronic address: bonnie.joe@ucsf.edu.
Abstract
OBJECTIVE: To evaluate outcomes of benign concordant magnetic resonance imaging (MRI)-guided breast biopsy. METHODS: We retrospectively reviewed 611 consecutive MRI-guided breast core biopsies at our institution from 2005 to 2012. Benign concordant cases with MRI follow-up constituted the study group. Lesion appearance on follow-up MRI was assessed and the false-negative rate was calculated. RESULTS: Eighty-four lesions in 68 women underwent benign concordant MRI-guided biopsy with subsequent MRI follow-up. Mean time to first follow-up MRI was 10.5 months. Two false negatives were identified on follow-up at 8 and 26 months. CONCLUSIONS: We report a false-negative rate of MRI-guided breast biopsy of 2.4%.
OBJECTIVE: To evaluate outcomes of benign concordant magnetic resonance imaging (MRI)-guided breast biopsy. METHODS: We retrospectively reviewed 611 consecutive MRI-guided breast core biopsies at our institution from 2005 to 2012. Benign concordant cases with MRI follow-up constituted the study group. Lesion appearance on follow-up MRI was assessed and the false-negative rate was calculated. RESULTS: Eighty-four lesions in 68 women underwent benign concordant MRI-guided biopsy with subsequent MRI follow-up. Mean time to first follow-up MRI was 10.5 months. Two false negatives were identified on follow-up at 8 and 26 months. CONCLUSIONS: We report a false-negative rate of MRI-guided breast biopsy of 2.4%.
Authors: J Lambert; T Steelandt; S H Heywang-Köbrunner; K Gieraerts; I Van Den Berghe; Ch Van Ongeval; J W Casselman Journal: Eur Radiol Date: 2021-01-18 Impact factor: 5.315